Thus, regulation of Rac1 gene expression by targeting the machinery responsible for its epigenetic modifications, e.g., Suv39H1, could prevent both histone and DNA methylation, ameliorating abnormalities in vascular and platelet dysfunction associated with diabetic retinopathy, and ultimately, slowing down/halting its progression. The gene discussed is RAC1; the disease is diabetic retinopathy.